IL6 and neoplasm: Specifically, certain strains of bacteria possess the capability to stimulate the interleukin-6 (IL-6), interleukin-10 (IL-10), and transforming growth factor-beta (TGF-β), consequently augmenting tumor proliferation and evading immune surveillance through targeted inhibition of cytotoxic T cells and natural killer (NK) cells.23